GuideAI Health (NEOE:GDAI) 5-Year Yield-on-Cost %: 0.00 (As of Sep. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NEOE:GDAI GuideAI Health Corp NEOE:GDAI
10 GF Score
Price C$1.25
View Full Analysis

What is GuideAI Health 5-Year Yield-on-Cost %?

GuideAI Health NEOE:GDAI +8.70% 10 5-Year Yield-on-Cost % is 0.00 as of Sep. 10, 2026. GuruFocus rates NEOE:GDAI with a GF Score™ of 10/100. Among 280 Healthcare Providers & Services companies, GuideAI Health ranks worse than 357142.5% on this metric.

GuideAI Health's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for GuideAI Health's 5-Year Yield-on-Cost % or its related term are showing as below:



NEOE:GDAI's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.925
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

GuideAI Health  (NEOE:GDAI) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


GuideAI Health 5-Year Yield-on-Cost % Related Terms


NEOE:GDAI vs VEEV, BTSG, TEM: 5-Year Yield-on-Cost % Comparison

For the Health Information Services subindustry, GuideAI Health's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GuideAI Health 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, GuideAI Health's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where GuideAI Health's 5-Year Yield-on-Cost % falls into.


NEOE:GDAI
10GF Score
GuideAI Health Corp NEOE:GDAI
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GuideAI Health 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of GuideAI Health is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
GuideAI Health (NEOE:GDAI) has a 5-Year Yield-on-Cost % of 0.00 as of Sep. 10, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on GuideAI Health and its competitors. According to the industry distribution chart, GuideAI Health ranks #999999 out of 280 companies in the Healthcare Providers & Services industry.
Is GuideAI Health's 5-Year Yield-on-Cost % too high?
GuideAI Health's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, GuideAI Health ranks #999999 out of 280 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, GuideAI Health has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does GuideAI Health's 5-Year Yield-on-Cost % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, GuideAI Health ranks #999999 out of 280 companies for 5-Year Yield-on-Cost %. This places GuideAI Health in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.93. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.93, based on 280 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on GuideAI Health and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GuideAI Health's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GuideAI Health stock overvalued right now?
GuideAI Health (NEOE:GDAI) has a current 5-Year Yield-on-Cost % of 0.00. The current 5-Year Yield-on-Cost % is 0.00. GuideAI Health's overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For GuideAI Health (NEOE:GDAI), the current 5-Year Yield-on-Cost % is 0.00 as of Sep. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GuideAI Health Business Description

Other Exchanges ZN0:Germany
Address 550 Burrard Street, Suite 2300, Vancouver, BC, CAN, V6C 2B5
GuideAI Health Corp is a healthcare technology company using artificial intelligence to enable the early detection of vascular disease and support more precise treatment decisions. Its platform analyzes routine CT scans to identify peripheral vascular disease and other vascular conditions that are frequently missed or under-reported, generating structured, actionable reports for radiologists and treating clinicians. By surfacing disease earlier and matching findings to appropriate treatment pathways, it aims to improve patient outcomes while helping hospitals and radiology groups deliver more comprehensive vascular care. Its Platform Capabilities are AI-powered vascular imaging, Early detection of disease, subtle patterns and risk signals, Structured, consistent AI-generated, and Others.
10GF Score

Get the complete analysis for NEOE:GDAI

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.25
Price